SCHEDULE 13G/A: Key Investor David Lisonbee and 4Life Research Disclose Significant Passive Stake in Clene Inc.

David Lisonbee and 4Life Research, LLC have disclosed their beneficial ownership in Clene Inc., collectively holding 6.5% and 3.7% of the common stock, respectively, as of December 20, 2024.

Summary

• 4Life Research, LLC beneficially owns 314,523 shares of Clene Inc. common stock, representing 3.7% of the class.
• This ownership for 4Life Research, LLC includes 199,844 shares of common stock and 114,679 shares issuable upon conversion of a convertible promissory note.
• David Lisonbee beneficially owns 555,328 shares of Clene Inc. common stock, representing 6.5% of the class.
• Lisonbee's total ownership encompasses shares held by 4Life Research, LLC (314,523 shares), Legato Investments, LLC (27,131 shares), La Scala Investments, LLC (114,679 shares from a convertible promissory note), and shares/warrants held directly (36,495 common shares and 62,500 shares underlying warrants).
• The convertible promissory notes contain a provision that limits the issuance of common shares upon conversion if such conversion, combined with warrant exercises, would necessitate stockholder approval under Nasdaq Stock Market rules.
• The filing explicitly states that the shares were not acquired and are not held for the purpose of changing or influencing the control of Clene Inc.
• The reported percentages of class are based on 8,248,719 shares of Common Stock outstanding as of January 21, 2025, as disclosed in Clene Inc.'s Registration Statement on Form S-3 filed on January 24, 2025.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. This is a routine ownership disclosure. The significant stake by a named individual and the explicit passive investment intent are generally viewed as positive signals of investor confidence, without implying control or active management changes.

Positives

• Significant beneficial ownership by a key individual (David Lisonbee) and associated entities, which can signal investor confidence in the company.
• The filing explicitly states that the shares were not acquired for the purpose of changing or influencing control, suggesting a passive investment stance and potentially reducing concerns about activist intervention.

Risks

• Potential future dilution from the conversion of convertible promissory notes and the exercise of warrants, although conversion is limited by Nasdaq rules requiring stockholder approval.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Clene Inc.'s future operational performance or strategic outlook.

Management Comments

• The filing includes a certification from David Lisonbee stating that the securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of Clene Inc.

Industry Context

This filing is a standard regulatory disclosure of a significant passive investment by an individual and associated entities in a publicly traded company. It provides transparency regarding a notable investor's stake but does not offer specific insights into Clene Inc.'s operational performance or broader industry trends.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily serves as a regulatory disclosure of beneficial ownership and does not contain information suitable for direct comparison to industry-specific operational or financial benchmarks. It indicates a significant, but non-controlling, stake by a specific investor group, which is a common occurrence in public markets.

Related Party Transactions

• David Lisonbee is the majority beneficial owner and manager of 4Life Research, LLC and Legato Investments, LLC, and majority beneficial owner and chairman of La Scala Investments, LLC. All these entities hold shares or convertible notes in Clene Inc., indicating related party holdings under his control.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant ownership stakes by key investors, which can influence market perception and liquidity.
• Management: Awareness of a significant, passive investor group, though the filing explicitly states no intent to influence control.

Key Dates

Keywords

Clene Inc., beneficial ownership, Schedule 13G, common stock, David Lisonbee, 4Life Research, convertible promissory note, Nasdaq rules, equity stake